Llwytho...
Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
BACKGROUND: In recent years, non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have been increasingly prescribed to adults with congenital heart disease (CHD) and atrial arrhythmias without good evidence for either safety or efficacy. To address this gap, we initiated an ongoing prospective...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cardiovasc Drugs Ther |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer US
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5591797/ https://ncbi.nlm.nih.gov/pubmed/28785894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-017-6745-y |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|